FRA2 Is a STAT5 target gene regulated by il-2 in human CD4 T cells

PLoS ONE

Volumn 9, Issue 2, 2014, Pages

  Rani, Aradhana ^a   Greenlaw, Roseanna ^a   Runglall, Manohursingh ^a   Jurcevic, Stipo ^a   John, Susan ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HISTONE H2B; HISTONE H3; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; STAT5 PROTEIN; TRANSCRIPTION FACTOR FRA 2;

ARTICLE; BINDING AFFINITY; BINDING SITE; CD4+ T LYMPHOCYTE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; FOS RELATED ANTIGEN 2 GENE; GENE IDENTIFICATION; GENE STRUCTURE; GENE TARGETING; HISTONE METHYLATION; HUMAN; HUMAN CELL; INTRON; PROMOTER REGION; PROTEIN FUNCTION; SEQUENCE ANALYSIS; TRANSCRIPTION INITIATION;

ANTIBODIES, MONOCLONAL, HUMANIZED; BASE SEQUENCE; BINDING SITES; CD4-POSITIVE T-LYMPHOCYTES; DNA, INTERGENIC; EPIGENESIS, GENETIC; FOS-RELATED ANTIGEN-2; GENE EXPRESSION REGULATION; GENES, REPORTER; HEK293 CELLS; HISTONES; HUMANS; IMMUNOGLOBULIN G; INTERLEUKIN-2; INTRONS; JANUS KINASE 3; LUCIFERASES; LYMPHOCYTE ACTIVATION; METHYLATION; MOLECULAR SEQUENCE DATA; PRIMARY CELL CULTURE; PROTEIN BINDING; SIGNAL TRANSDUCTION; STAT5 TRANSCRIPTION FACTOR; TRANSCRIPTION, GENETIC;

EID: 84896520514     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0090370     Document Type: Article

References (54)

1. Stark GR, Darnell JE, Jr. (2012) The JAK-STAT pathway at twenty. Immunity 36: 503-514.
2. Gatzka M, Piekorz R, Moriggl R, Rawlings J, Ihle JN (2006) A role for STAT5A/B in protection of peripheral T-lymphocytes from postactivation apoptosis: insights from gene expression profiling. Cytokine 34: 143-154. (Pubitemid 44038569)
3. Nagy ZS, LeBaron MJ, Ross JA, Mitra A, Rui H, et al. (2009) STAT5 regulation of BCL10 parallels constitutive NFkappaB activation in lymphoid tumor cells. Mol Cancer 8: 67.
4. Liao W, Schones DE, Oh J, Cui Y, Cui K, et al. (2008) Priming for T helper type 2 differentiation by interleukin 2-mediated induction of interleukin 4 receptor alpha-chain expression. Nat Immunol 9: 1288-1296.
5. Nagy ZS, Ross JA, Rodriguez G, Balint BL, Szeles L, et al. (2013) Genome wide mapping reveals PDE4B as an IL-2 induced STAT5 target gene in activated human PBMCs and lymphoid cancer cells. PLoS One 8: e57326.
6. Nelson EA, Walker SR, Alvarez JV, Frank DA (2004) Isolation of unique STAT5 targets by chromatin immunoprecipitation-based gene identification. J Biol Chem 279: 54724-54730. (Pubitemid 40053217)
7. LeBaron MJ, Xie J, Rui H (2005) Evaluation of genome-wide chromatin library of Stat5 binding sites in human breast cancer. Mol Cancer 4: 6.
8. Bell BD, Kitajima M, Larson RP, Stoklasek TA, Dang K, et al. (2013) The transcription factor STAT5 is critical in dendritic cells for the development of TH2 but not TH1 responses. Nat Immunol 14: 364-371.
9. Yamane H, Zhu J, Paul WE (2005) Independent roles for IL-2 and GATA-3 in stimulating naive CD4+ T cells to generate a Th2-inducing cytokine environment. J Exp Med 202: 793-804. (Pubitemid 41345968)
10. Rani A, Afzali B, Kelly A, Tewolde-Berhan L, Hackett M, et al. (2011) IL-2 regulates expression of C-MAF in human CD4 T cells. J Immunol 187: 3721-3729.
11. Lund RJ, Loytomaki M, Naumanen T, Dixon C, Chen Z, et al. (2007) Genomewide identification of novel genes involved in early Th1 and Th2 cell differentiation. J Immunol 178: 3648-3660. (Pubitemid 46417632)
12. Ciofani M, Madar A, Galan C, Sellars M, Mace K, et al. (2012) A validated regulatory network for Th17 cell specification. Cell 151: 289-303.
13. Foletta VC (1996) Transcription factor AP-1, and the role of Fra-2. Immunol Cell Biol 74: 121-133. (Pubitemid 26173819)
14. Nishina H, Sato H, Suzuki T, Sato M, Iba H (1990) Isolation and characterization of fra-2, an additional member of the fos gene family. Proc Natl Acad Sci U S A 87: 3619-3623.
15. Nakayama T, Higuchi T, Oiso N, Kawada A, Yoshie O (2012) Expression and function of FRA2/JUND in cutaneous T-cell lymphomas. Anticancer Res 32: 1367-1373.
16. Crawford GE, Holt IE, Mullikin JC, Tai D, Blakesley R, et al. (2004) Identifying gene regulatory elements by genome-wide recovery of DNase hypersensitive sites. Proceedings of the National Academy of Sciences of the United States of America 101: 992-997. (Pubitemid 38160572)
17. Mi H, Muruganujan A, Thomas PD (2013) PANTHER in 2013: modeling the evolution of gene function, and other gene attributes, in the context of phylogenetic trees. Nucleic Acids Res 41: D377-386.
18. John S, Vinkemeier U, Soldaini E, Darnell JE, Jr., Leonard WJ (1999) The significance of tetramerization in promoter recruitment by Stat5. Mol Cell Biol 19: 1910-1918. (Pubitemid 29098249)
19. Wang Q, Carroll JS, Brown M (2005) Spatial and temporal recruitment of androgen receptor and its coactivators involves chromosomal looping and polymerase tracking. Mol Cell 19: 631-642. (Pubitemid 41219439)
20. Robertson G, Hirst M, Bainbridge M, Bilenky M, Zhao Y, et al. (2007) Genomewide profiles of STAT1 DNA association using chromatin immunoprecipitation and massively parallel sequencing. Nat Methods 4: 651-657. (Pubitemid 47202477)
21. Martone R, Euskirchen G, Bertone P, Hartman S, Royce TE, et al. (2003) Distribution of NF-kappaB-binding sites across human chromosome. Proc Natl Acad Sci U S A 100: 12247-12252. (Pubitemid 37271546)
22. Carroll JS, Meyer CA, Song J, Li W, Geistlinger TR, et al. (2006) Genome-wide analysis of estrogen receptor binding sites. Nat Genet 38: 1289-1297. (Pubitemid 44646291)
23. Soldaini E, John S, Moro S, Bollenbacher J, Schindler U, et al. (2000) DNA binding site selection of dimeric and tetrameric Stat5 proteins reveals a large repertoire of divergent tetrameric Stat5a binding sites. Mol Cell Biol 20: 389-401. (Pubitemid 30002580)
24. Iyer VR, Horak CE, Scafe CS, Botstein D, Snyder M, et al. (2001) Genomic binding sites of the yeast cell-cycle transcription factors SBF and MBF. Nature 409: 533-538. (Pubitemid 32144361)
25. Lin JX, Li P, Liu D, Jin HT, He J, et al. (2012) Critical Role of STAT5 transcription factor tetramerization for cytokine responses and normal immune function. Immunity 36: 586-599.
26. Moriggl R, Sexl V, Kenner L, Duntsch C, Stangl K, et al. (2005) Stat5 tetramer formation is associated with leukemogenesis. Cancer Cell 7: 87-99. (Pubitemid 40126385)
27. Greif PA, Eck SH, Konstandin NP, Benet-Pages A, Ksienzyk B, et al. (2011) Identification of recurring tumor-specific somatic mutations in acute myeloid leukemia by transcriptome sequencing. Leukemia 25: 821-827.
28. Futreal PA, Coin L, Marshall M, Down T, Hubbard T, et al. (2004) A census of human cancer genes. Nat Rev Cancer 4: 177-183. (Pubitemid 38337497)
29. Pasqualucci L, Trifonov V, Fabbri G, Ma J, Rossi D, et al. (2011) Analysis of the coding genome of diffuse large B-cell lymphoma. Nat Genet 43: 830-837.
30. Pleasance ED, Cheetham RK, Stephens PJ, McBride DJ, Humphray SJ, et al. (2010) A comprehensive catalogue of somatic mutations from a human cancer genome. Nature 463: 191-196.
31. Ding L, Getz G, Wheeler DA, Mardis ER, McLellan MD, et al. (2008) Somatic mutations affect key pathways in lung adenocarcinoma. Nature 455: 1069-1075.
32. Jones S, Zhang X, Parsons DW, Lin JC, Leary RJ, et al. (2008) Core signaling pathways in human pancreatic cancers revealed by global genomic analyses. Science 321: 1801-1806.
33. Stransky N, Egloff AM, Tward AD, Kostic AD, Cibulskis K, et al. (2011) The mutational landscape of head and neck squamous cell carcinoma. Science 333: 1157-1160.
34. Berger MF, Lawrence MS, Demichelis F, Drier Y, Cibulskis K, et al. (2011) The genomic complexity of primary human prostate cancer. Nature 470: 214-220.
35. Wood LD, Parsons DW, Jones S, Lin J, Sjoblom T, et al. (2007) The genomic landscapes of human breast and colorectal cancers. Science 318: 1108-1113. (Pubitemid 350134889)
36. Clark MJ, Homer N, O'Connor BD, Chen Z, Eskin A, et al. (2010) U87MG decoded: the genomic sequence of a cytogenetically aberrant human cancer cell line. PLoS Genet 6: e1000832.
37. Totoki Y, Tatsuno K, Yamamoto S, Arai Y, Hosoda F, et al. (2011) Highresolution characterization of a hepatocellular carcinoma genome. Nat Genet 43: 464-469.
38. Gui Y, Guo G, Huang Y, Hu X, Tang A, et al. (2011) Frequent mutations of chromatin remodeling genes in transitional cell carcinoma of the bladder. Nat Genet 43: 875-878.
39. Rascle A, Johnston JA, Amati B (2003) Deacetylase activity is required for recruitment of the basal transcription machinery and transactivation by STAT5. Mol Cell Biol 23: 4162-4173. (Pubitemid 36666421)
40. Boyle AP, Davis S, Shulha HP, Meltzer P, Margulies EH, et al. (2008) Highresolution mapping and characterization of open chromatin across the genome. Cell 132: 311-322. (Pubitemid 351172431)
41. Barski A, Cuddapah S, Cui K, Roh TY, Schones DE, et al. (2007) Highresolution profiling of histone methylations in the human genome. Cell 129: 823-837. (Pubitemid 46802390)
42. Wang Z, Zang C, Rosenfeld JA, Schones DE, Barski A, et al. (2008) Combinatorial patterns of histone acetylations and methylations in the human genome. Nat Genet 40: 897-903. (Pubitemid 351913645)
43. Berger SL (2007) The complex language of chromatin regulation during transcription. Nature 447: 407-412. (Pubitemid 46816746)
44. Shahbazian MD, Grunstein M (2007) Functions of site-specific histone acetylation and deacetylation. Annu Rev Biochem 76: 75-100.
45. Li B, Carey M, Workman JL (2007) The role of chromatin during transcription. Cell 128: 707-719. (Pubitemid 46273570)
46. McDyer JF, Li Z, John S, Yu X, Wu CY, et al. (2002) IL-2 receptor blockade inhibits late, but not early, IFN-gamma and CD40 ligand expression in human T cells: disruption of both IL-12-dependent and-independent pathways of IFNgamma production. J Immunol 169: 2736-2746. (Pubitemid 34921023)
47. Velotta JB, Deuse T, Haddad M, Masuda E, Park G, et al. (2009) A novel JAK3 inhibitor, R348, attenuates chronic airway allograft rejection. Transplantation 87: 653-659.
48. Ehret GB, Reichenbach P, Schindler U, Horvath CM, Fritz S, et al. (2001) DNA binding specificity of different STAT proteins. Comparison of in vitro specificity with natural target sites. J Biol Chem 276: 6675-6688.
49. Fung MM, Chu YL, Fink JL, Wallace A, McGuire KL (2005) IL-2-and STAT5-regulated cytokine gene expression in cells expressing the Tax protein of HTLV-1. Oncogene 24: 4624-4633. (Pubitemid 41032600)
50. Crawford GE, Holt IE, Whittle J, Webb BD, Tai D, et al. (2006) Genome-wide mapping of DNase hypersensitive sites using massively parallel signature sequencing (MPSS). Genome research 16: 123-131. (Pubitemid 43048941)
51. Hoelbl A, Schuster C, Kovacic B, Zhu B, Wickre M, et al. (2010) Stat5 is indispensable for the maintenance of bcr/abl-positive leukaemia. EMBO Mol Med 2: 98-110.
52. Barash I (2012) Stat5 in breast cancer: potential oncogenic activity coincides with positive prognosis for the disease. Carcinogenesis 33: 2320-2325.
53. Ferbeyre G, Moriggl R (2011) The role of Stat5 transcription factors as tumor suppressors or oncogenes. Biochim Biophys Acta 1815: 104-114.
54. Yu H, Pardoll D, Jove R (2009) STATs in cancer inflammation and immunity: a leading role for STAT3. Nat Rev Cancer 9: 798-809.